Improving the Healthcare System for African American Patients
At HCPLive, we’ve had the incredible privilege of speaking with doctors from a variety of different clinical fields as well as different cultural, racial, and ethnic backgrounds. Without their dedication, insights, and generosity, the health care system and the world at large would be at a loss.    Even publications such as our own benefit from their work in a myriad of ways. In this episode ...
14m Feb 24, 2022
14m
Efficacy of Guselkumab for Treating Psoriatic Arthritis
Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a Network Meta-Analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.
16m Feb 23, 2022
16m
Improving Telemedicine for Black Patients with Heart Disease
Across all areas of study in health care and especially in recent years, African American patients and physicians have experienced racial inequity regarding telemedicine practices across the US.    However, a new pilot trial (https://www.hcplive.com/view/reaching-black-patients-heart-disease-study-benefit-texting-versus-online-portals) from the Perelman School of Medicine at the University of...
16m Feb 21, 2022
16m
How Rheumatology Patients Should Be Vaccinated for COVID-19
In early February, the American College of Rheumatology (ACR) announced (https://www.hcplive.com/view/acr-updates-covid-19-vaccine-guidance--fourth-doses-recommendations) an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases. (https://www.rheumatology.org/Portals/0/Files/COVID-19-Vaccine-Clinical-Guidance-Rheumatic-Diseases-Summary...
15m Feb 16, 2022
15m
An Interplay Between Solutions and Success In Physician Burnout with Janae Sharp
In this episode of DocTalk, we interview Janae Sharp, founder of the Sharp index, on some of these larger, slightly philosophical questions surrounding physician burnout, including how to measure and define success, as well as the deeper layers of stigma that must be addressed as part of the process.
27m Feb 15, 2022
27m
The Cultural and Clinical Challenges of Sickle Cell with Ifeyinwa “Ify” Osunkwo, MD
Though sickle cell disease (https://www.hcplive.com/clinical/sickle-cell) had been present in Africa for over 5000 years, it was first “discovered” in 1910 when a dental student named Walter Clement Noel became the first patient to be formally diagnosed. From there, more would be uncovered about the disease in the decades following his diagnosis, such as how it disproportionately affects patien...
20m Feb 09, 2022
20m
Examining Pediatric Myocarditis Risk with COVID-19 Vaccination with Matthew E. Oster, MD, MPH
In late January, a team of investigators from the Centers for Disease Control and Prevention (CDC) reported findings (https://www.hcplive.com/view/young-men-adolescents-raised-risk-covid-19-mrna-vaccine-myocarditis) from the Vaccine Adverse Event Reporting System (VAERS) indicating a significantly low risk of myocarditis following vaccination with either available messenger RNA (mRNA) vaccine f...
13m Feb 07, 2022
13m
Addressing Gender Inequality in the Medical Field with Marcia Klein-Patel, MD
Today marks the fourth-ever National Women Physicians Day, an event that that is intended to pay respect to women physicians across the country. It’s held each year on Elizabeth Blackwell's birthday, who was the first female medical doctor in the United States.   Though much has changed since then, there are still fewer female doctors nationally than male doctors, an issue often caused by gend...
10m Feb 02, 2022
10m
Guselkumab Ranked Highest Overall in Skin Clearance with Philip Mease, MD
Last week, Janssen announced results (https://www.hcplive.com/view/guselkumab-ranked-highest-skin-clearance-psoriatic-arthritis) from a network meta-analysis (NMA) that showed that the biologic therapy guselkumab ranked highest for overall level of skin clearance. The NMA involved 33 phase 3 randomized clinical trials and 15 different targeted therapies including risakinumab and more. Philip J...
19m Jan 31, 2022
19m
Physician Burnout Reaching Critical Levels During COVID-19 with Lakshmana Swamy, MD, MBA
Prior to the COVID-19 (https://www.hcplive.com/clinical/coronavirus) pandemic, the subject of physician burnout was likely not considered or completely understood by large swaths of the American public. Despite this, burnout has been an issue that has plagued physicians for decades prior to the pandemic, and the consequences of it are far-reaching.   In an interview for the latest installment...
13m Jan 26, 2022
13m
Launching the Institute for Airway Sciences with Eric Genden, MD, MBA
In mid-January, Mount Sinai Health System and Icahn School of Medicine announced the launch of the Institute for Airway Sciences (IAS) (https://www.hcplive.com/view/mount-sinai-launches-institute-for-airway-sciences) , a multidisciplinary institute intended to establish new therapies for patients with sinus, laryngotracheal airway, and lung diseases. The institute will be opened under the guid...
11m Jan 22, 2022
11m
Sickle Cell Management During the Blood Crisis with Edward Ivy, MD, MPH
In January, The American Red Cross reported that it was facing “its worst blood shortage in over a decade” amid surging cases of the Omicron variant of the COVID-19 virus. For the first time since its inception, the Red Cross declared a “Blood Crisis”, with blood and platelet donations reaching critically low levels. Among those affected are patients with sickle cell disease. Edward Ivy, MD, ...
12m Jan 19, 2022
12m
Detailing COPD Prevalence in Low and Middle-Income Countries
With Chronic Obstructive Pulmonary Disease (COPD) (https://www.hcplive.com/clinical/copd) being cited as the third leading cause of mortality globally, the data surrounding the condition has naturally continued to broaden. In high-income countries, COPD is predominantly typically linked to cigarette exposure, tobacco smoke and poor sleep habits.  However, people in low- and middle-income coun...
11m Jan 17, 2022
11m
Detailing Current Flu Vaccine Research with Keipp Talbot, MD, MPH
With the Centers for Disease Control and Prevention observing a steady increase in influenza (https://www.hcplive.com/view/flu-cases-continue-to-rise-early-in-the-year) cases early in the year, the subject of influenza vaccination has become increasingly prevalent. Keipp Talbot, MD, MPH, Associate Professor of Medicine in the Division of Infectious Diseases at Vanderbilt University, sat down w...
14m Jan 12, 2022
14m
FDA Approves Tralokinumab for Atopic Dermatitis
DocTalk returns in 2022 with a discussion of the recent Food and Drug Administration (FDA) approval (https://www.hcplive.com/view/fda-approves-tralokinumab-ldrm-atopic-dermatitis-adults) of tralokinumab for the treatment of moderate-to-severe atopic dermatitis in adult patients.  For this episode, Jonathan Silverberg, MD, PhD, MPH, discusses the ECZTRA trials, 3 phase 3 trials that evaluated t...
8m Jan 10, 2022
8m
Theresa Cerulli, MD: Explaining Complex ADHD
23m Dec 30, 2021
23m
Brent Moody, MD: The Implications of E/M Code Changes on Dermatology Care
In this Derm Discussions, Moody speaks to how the coding changes can aid in streamlining billing documentation for dermatologists.
18m Dec 21, 2021
18m
Paul S. Jellinger, MD: A Multidisciplinary Approach to Diabetes Care
Dr. Jellinger joins the podcast to discuss the lipid section of the DCRM Multispecialty Practice Recommendations, as well the role of combination therapies and other concepts to lower LDL and what is coming next for the field of diabetes in 2022. 
39m Dec 21, 2021
39m
What We Know About the Omicron Variant
Donald Alcendor, PhD, joins to review currently available data surrounding the newest COVID-19 variant of concern, and shares guidance for concerned clinicians and the general public.
25m Dec 08, 2021
25m
Impact of COVID-19 on Quality of Life of Patients With Rheumatic Disease
On this month's episode, we interviewed Courtney Wells, PhD, MPH, MSW, to discuss the impact of COVID-19 on the quality of life of patients with rheumatic conditions, focusing on perceived risk and decision making.
13m Dec 06, 2021
13m
Unmet Patient Needs in Rheumatic Disease
Soumya Chakravarty, MD, PhD, discusses the unmet patient needs in immune-mediated diseases as well as Janssen’s work in scientific innovation that allows patients to live their lives more unburdened by their disease. Chakravarty is the Sr Director and Strategic Lead in the Rheumatology Therapeutics area at Janssen.
25m Nov 23, 2021
25m
Port Delivery System 101 with Carl Regillo, MD
The Director of Retina Services at Wills Eye Hospital joins to discuss the historic FDA approval granted for a novel method of ophthalmic care: a permanent implant that allows for vision-saving formula therapy to treat the eye continually. Read more about the PDS approval here. (https://www.hcplive.com/view/fda-approves-port-delivery-system-ranibizumab-wet-amd) Episode notes: 0:12 Intro 1:07...
30m Nov 16, 2021
30m
Arianna Yanes, MD: Detailing the “Skin Conditions in Students” Handouts
Dr. Arianna Yanes provides insights into 7 new handouts developed by the Society for Pediatric Dermatology and how they aid nurses and teachers in creating a more inclusive setting for children with skin conditions.
14m Nov 10, 2021
14m
Vaccine Hesitancy Among Patients With IBD
19m Nov 03, 2021
19m
Controversies in Osteoporosis
E. Michael Lewiecki, MD, discusses “Controversies in Osteoporosis” and “What's New in Osteoporosis for 2021?” We deep dive into recent controversies and trends in osteoporosis management, predictions for 2022, and how COVID-19 had impacted the treatment landscape for rheumatologists.
20m Oct 25, 2021
20m
Ranibizumab PDS, Faricimab, Gene Therapy and Top ASRS 2021 Headlines
Josh Mali, MD, of The Eyes Associates, joins HCPLive to review the key news and developments coming out of the American Society of Retina Specialists 2021 Scientific Meeting.
22m Oct 09, 2021
22m
Yamalis Diaz, PhD: The Current State of ADHD Care
18m Sep 22, 2021
18m
William Chey, MD: Treating Gastrointestinal Diseases With Diet
26m Sep 20, 2021
26m
The Current State of Vitiligo and Alopecia Areata Research
In this Derm Discussions, experts review the state of clinical innovation driving new opportunities in chronic skin disease care.
34m Sep 15, 2021
34m
Rare Disease Report: Niemann-Pick Disease
Sharon Hrynkow, PhD, joins the Rare Disease Report to discuss the ultra rare and heterogenous lysosomal storage disorder.
29m Aug 04, 2021
29m
Safety of JAK Inhibitors
Roy Fleischmann, MD, discusses the recent Pfizer press release touching upon the safety of JAK inhibitors. He explains the recent scrutiny of JAKs, the concerns some rheumatologists have in regard to JAK inhibitors, and his personal opinions on prescribing JAK inhibiting drugs to his patients.
13m Aug 02, 2021
13m
The Promise of Janus Kinase Inhibitors
In this Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.
28m Jul 26, 2021
28m
Value-Based Care in Rheumatology
Rheumatology Network sat down with Andrew L Concoff MD, FACR, CAQSM, to discuss value-based care, including the benefits, collaborate approach to working with payers, the revenue and cost savings, and how value-based care can support routine and consistent health visits.
24m Jul 12, 2021
24m
Rare Disease Report: Charcot-Marie-Tooth Disease
Florian Thomas, MD, and Adrian Hepner, MD, cover the basics of the degenerative nerve disorder.
27m Jul 07, 2021
27m
Rare Disease Report: Leber's Congenital Amaurosis
Stephen Russell, MD, talks about promising new data that has the potential to provide a breakthrough for treating the most common mutation of the rare genetic eye disease.
24m Jun 24, 2021
24m
James Lewis, MD: Diet as Treatment in Patients with Crohn's Disease
34m Jun 17, 2021
34m
Ann C. Childress, MD: The Promise of Viloxazine for Pediatric ADHD
Dr. Childress said COVID-19 was difficult for many pediatric patients with ADHD
23m Jun 15, 2021
23m
CreakyJoints Espanol
This week, we sat down with Daniel Hernandez, MD, and Shilpa Venkatachalam, PhD, MPH, of CreakyJoints, to highlight health disparities in marginalized communities and introduce their exciting new venture, CreakyJoints Espanol.
19m Jun 14, 2021
19m
Intersections Between Climate Change and Dermatology
In this Derm Discussions, Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of dermatology.
35m May 30, 2021
35m
Rare Disease Report: Cystic Fibrosis
Jordana Hoppe, MD, discusses the burden of cystic fibrosis on infants and children.
28m May 28, 2021
28m
Overdrive: Guselkumab Efficacy for Psoriatic Arthritis
We sat down with Philip J. Mease, MD, to discuss his study, “Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.” Time stamps: 0:35: Can you begin by giving me a general overview of the current treatment landscape for psoriatic arthritis? 2:12: Have you noticed any trends in treating psoriatic arthritis? 3:00: Wh...
11m May 07, 2021
11m
Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness
Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.
19m May 07, 2021
19m
Rare Disease Report: Sarcoidosis
Ennis James, MD, discusses the challenges and lingering questions associated with the treatment of sarcoidosis.
17m Apr 19, 2021
17m
Mary Rooney, PhD: The Challenges of ADHD During a Pandemic
27m Mar 18, 2021
27m
Rare Disease Report: Fabry Disease
Eric Wallace, MD, discusses Anderson-Fabry disease and the difficulties associated with screening, testing, and treatment.
29m Mar 16, 2021
29m
What's New in Cosmetic Dermatology
In this Derm Discussions, Valerie Callender, MD, draws on her experiences in clinical practice to discuss cosmetic dermatology care practices and the challenges of this past year.
34m Mar 07, 2021
34m
Rare Disease Report: Sickle Cell Disease
Kim Smith-Whitley, MD, discusses the history, presentations, and research status of sickle cell disease.
31m Feb 28, 2021
31m
Remote Cardiological Care in Children
In a joint interview, 2 pediatric cardiologists discuss topics related to remote technologies and cardiological monitoring among pediatric populations. 
22m Feb 15, 2021
22m
Surveying the Dermatological Treatment Landscape
In this Derm Discussions, Todd Schlesinger, MD, talks new therapies on the horizon and those that have already proven efficacious.
25m Jan 31, 2021
25m
Cardiovascular Guidelines in Diabetics with Dr. George Bakris
The University of Chicago hypertension expert discusses new ADA recommendations for cardiovascular risk management.
35m Jan 25, 2021
35m